Acceleron Pharma
(XLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -197,457 | -126,992 | -63,471 | -166,030 | -108,635 |
| Depreciation Amortization | 3,222 | 2,062 | 1,026 | 3,845 | 2,841 |
| Accounts receivable | -8,094 | -1,836 | 894 | -17,554 | -14,014 |
| Accounts payable and accrued liabilities | -3,418 | 542 | -4,178 | 5,830 | 6,315 |
| Other Working Capital | -67,190 | -53,055 | -17,887 | 243 | -9,760 |
| Other Operating Activity | 49,710 | 26,940 | 15,692 | 43,339 | 31,056 |
| Operating Cash Flow | $-223,227 | $-152,339 | $-67,924 | $-130,327 | $-92,197 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 280,322 | 195,019 | 119,851 | 268,027 | 220,240 |
| PPE Investments | -4,298 | -1,889 | -920 | -4,203 | -3,303 |
| Purchase Of Investment | -407,580 | -381,477 | -270,144 | -238,228 | -161,741 |
| Investing Cash Flow | $-131,556 | $-188,347 | $-151,213 | $25,596 | $55,196 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | N/A | N/A | 492,414 | 492,414 |
| Other Financing Activity | 20,086 | 5,933 | 3,698 | 45,592 | 36,595 |
| Financing Cash Flow | $20,086 | $5,933 | $3,698 | $538,006 | $529,009 |
| Beginning Cash Position | 672,549 | 672,549 | 672,549 | 239,274 | 239,274 |
| End Cash Position | 337,852 | 337,796 | 457,110 | 672,549 | 731,282 |
| Net Cash Flow | $-334,697 | $-334,753 | $-215,439 | $433,275 | $492,008 |
| Free Cash Flow | |||||
| Operating Cash Flow | -223,227 | -152,339 | -67,924 | -130,327 | -92,197 |
| Capital Expenditure | -4,298 | -1,889 | -920 | -4,203 | -3,303 |
| Free Cash Flow | -227,525 | -154,228 | -68,844 | -134,530 | -95,500 |